| Bioactivity | PAC1R antagonist 1 (compound 3d) is a potent and orally active antagonist of PAC1 receptor. PAC1R antagonist 1 can inhibit pituitary adenylate cyclase-activating polypeptide (PACAP)- and nerve injury-induced allodynia[1]. |
| Name | PAC1R antagonist 1 |
| CAS | 2305204-24-2 |
| Formula | C17H17ClN6O2 |
| Molar Mass | 372.81 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Takasaki I, et, al. Synthesis of a novel and potent small-molecule antagonist of PAC1 receptor for the treatment of neuropathic pain. Eur J Med Chem. 2020 Jan 15;186:111902. |
PAC1R antagonist 1
CAS: 2305204-24-2 F: C17H17ClN6O2 W: 372.81
PAC1R antagonist 1 (compound 3d) is a potent and orally active antagonist of PAC1 receptor. PAC1R antagonist 1 can inhib
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.